Cychlorphine Is Not Detected by Fentanyl Test Strips
🧪 Know What Your Test Strips Can — and Can't — Detect
Fentanyl continues to appear throughout the unregulated supply, and test strips remain one of the most accessible ways to screen for it. Just understand what a negative result does and does not tell you.
Explore Fentanyl Test Strips →San Francisco identified its first fatal overdose involving cychlorphine after the death of a 16-year-old resident.
Cychlorphine is an emerging synthetic opioid reportedly estimated to be approximately 10 times more potent than fentanyl. Standard fentanyl test strips do not detect it.
That does not make fentanyl test strips ineffective. It shows why a test designed to detect one drug or drug family cannot rule out every opioid that may be circulating.
What Was Found in the San Francisco Case
The teenager was found unresponsive in April 2026. His mother administered two doses of naloxone, but he could not be revived.
The autopsy later detected cychlorphine along with N-desethyl isotonitazene, another synthetic opioid, and ethyl bromazolam, an unapproved benzodiazepine.
That combination matters. The death should not be reduced to a simple claim that cychlorphine alone caused the overdose or that naloxone does not work against it. Multiple central nervous system depressants were detected, and we do not know whether earlier intervention or additional naloxone would have changed the outcome.
⚠️ Naloxone should still be administered whenever an opioid overdose is suspected. Call emergency services immediately, provide rescue breathing when appropriate and give additional doses if the person does not respond.
Why Fentanyl Test Strips Did Not Detect Cychlorphine
Fentanyl test strips are targeted tools. They detect fentanyl and may respond to certain closely related compounds, but they are not universal opioid tests.
Cychlorphine has a different chemical structure. A sample can therefore test negative with standard fentanyl test strips and still contain cychlorphine or another synthetic opioid outside the test's detection range.
This is one of the most important fentanyl test strip limitations to understand: a negative result means fentanyl was not detected in the portion tested. It does not mean the sample contains no opioids, and it does not establish that the sample is safe.
Testing one portion also cannot account for uneven distribution throughout a pill, powder or larger supply.
New Synthetic Opioids Complicate Drug Checking
The illicit supply is changing faster than many consumer testing technologies can be developed, validated and distributed.
Separate test strips are available for some emerging drug classes, including nitazenes. Those tools only screen for the compounds or families they are designed to detect. They should not be assumed to detect cychlorphine or every nitazene without compound-specific validation.
Reagent testing can provide additional presumptive information, but it cannot reliably identify trace amounts of every potent synthetic opioid. Results that look consistent with the expected substance do not rule out additional compounds.
Mail-in laboratory testing provides more comprehensive identification, although even laboratory results apply only to the sample submitted. No testing method can guarantee safety or predict the effects of a mixture.
Every Strip Answers One Question. Stack Them.
No single strip covers the whole supply. Screening for fentanyl, xylazine and nitazenes separately gives you more layers of information than any one test alone.
Explore Fentanyl Test Strips →What Fentanyl Test Strips Can Still Do
Fentanyl test strips remain an important harm-reduction tool because fentanyl continues to appear throughout the unregulated supply.
Their limitation is not that they provide no useful information. Their limitation is that they answer a specific question.
The Transparency Triple Check
The Transparency Triple Check combines multiple forms of drug checking:
- Test strips screen for fentanyl, xylazine, nitazenes or other targeted compounds when applicable.
- Multiple reagents evaluate whether a sample reacts consistently with the substance expected.
- The free Transparency App provides lab-verified reaction videos for comparison.
These steps provide different layers of information. None can rule out cychlorphine or every emerging synthetic opioid.
A Negative Fentanyl Test Is Not an All-Clear
San Francisco reportedly found cychlorphine in pills collected during other investigations, suggesting the compound was not limited to a single case.
The city had previously used wastewater testing to monitor emerging substances, but federal funding ended in 2024. Testing resumed in July 2026, with public reporting expected to follow.
A community should not have to learn that a new opioid has arrived through an autopsy.
⚠️ Remember: Fentanyl test strips can reduce uncertainty about fentanyl. Understanding what they cannot detect is just as important. Keep naloxone available, avoid using alone, start with a small amount and treat every negative result as one piece of information rather than proof of safety.
A Negative Result Is Information, Not an All-Clear.
Fentanyl test strips answer one specific question, and that answer still matters. Keep them on hand, keep naloxone nearby, and treat every result as one piece of the picture.
Explore Fentanyl Test Strips →Ships discreetly | Results in minutes
Related Resources
Learn more about drug checking and what each tool can detect:
- How to Test for Fentanyl – Step-by-step instructions for using fentanyl test strips
- How to Test for Nitazenes – Using nitazene test strips and what they screen for
- How to Test for Xylazine – Instructions for xylazine test strips
- Transparency Testing Lab Services – Drug-checking laboratory analysis for comprehensive identification
Sources
Source: SFist reporting on San Francisco's first fatal overdose involving cychlorphine
